Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Familial hypercholesterolemia in children.

J Rodenburg1, M N Vissers, A Wiegman

  • 1Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, The Netherlands.

Current Opinion in Lipidology
|July 10, 2004
PubMed
Summary

Children with familial hypercholesterolemia experience accelerated atherosclerosis. Early statin therapy is safe and effective in reducing low-density lipoprotein cholesterol and improving arterial health in these children.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genotype-phenotype correlation in a large cohort of pediatric patients with heterozygous and homozygous familial hypercholesterolemia.

Current opinion in lipidology·2023
Same author

The windsor definition for hyperemesis gravidarum: A multistakeholder international consensus definition.

European journal of obstetrics, gynecology, and reproductive biology·2021
Same author

[Detection and treatment of familial hypercholesterolaemia; the earlier, the better?]

Nederlands tijdschrift voor geneeskunde·2020
Same author

A core outcome set for hyperemesis gravidarum research: an international consensus study.

BJOG : an international journal of obstetrics and gynaecology·2020
Same author

Pediatric lipid reference values in the general population: The Dutch lifelines cohort study.

Journal of clinical lipidology·2018
Same author

Cardiovascular imaging in children and adults following Kawasaki disease.

Insights into imaging·2015

Area of Science:

  • Pediatric Cardiology
  • Genetics
  • Cardiovascular Disease

Background:

  • Familial hypercholesterolemia (FH) is a genetic disorder leading to high cholesterol levels from birth.
  • Children with FH face an increased risk of premature cardiovascular disease due to accelerated atherosclerosis.
  • Early detection and intervention are crucial for managing FH in pediatric populations.

Purpose of the Study:

  • To review recent advancements in diagnosing and managing pediatric familial hypercholesterolemia.
  • To highlight the impact of early lipid-lowering interventions on cardiovascular health in children with FH.

Main Methods:

  • Cross-sectional cohort study analyzing intima-media thickness progression in children with FH.
  • Evaluation of low-density lipoprotein cholesterol as a predictor of atherosclerosis.

Related Experiment Videos

  • Assessment of statin therapy and plant sterol products for lipid reduction and surrogate marker improvement.

    • Main Results:

    • Children with FH showed a 5-fold faster increase in carotid arterial wall intima-media thickness compared to unaffected siblings.
    • Low-density lipoprotein cholesterol levels were a strong predictor of intima-media thickness.
    • Statin therapy led to regression of intima-media thickness and was found to be safe in children, without impairing growth or development.
    • Plant sterols reduced low-density lipoprotein cholesterol but did not improve endothelial function.

    Conclusions:

    • Children with FH significantly benefit from lipid-lowering strategies, particularly statins.
    • Statins are safe and effective in reducing low-density lipoprotein cholesterol and improving atherosclerosis markers in pediatric FH.
    • Early initiation of statin therapy is recommended as the pivotal treatment for children with familial hypercholesterolemia.